• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-1β对非小细胞肺癌衍生的小细胞外囊泡在介导癌症进展和逃避免疫系统中的作用

Effect of IL-1β on NSCLC-Derived Small Extracellular Vesicles as Actors in Mediating Cancer Progression and Evading Immune System.

作者信息

Heydari Sheikhhossein Hamid, Amato Luisa, De Rosa Viviana, De Rosa Caterina, Ariano Annalisa, Critelli Sabrina, Omodei Daniela, Nele Valeria, Tuccillo Concetta, Franco Paola, Roviello Giovanni N, Camerlingo Rosa, Piattelli Adriano, Vicidomini Giovanni, Morgillo Floriana, De Rosa Giuseppe, Stoppelli Maria Patrizia, Della Corte Carminia Maria, Di Pietro Natalia, Iommelli Francesca

机构信息

Department of Medical, Oral and Biotechnological Sciences, University "G. d'Annunzio" of Chieti-Pescara, 66100 Chieti, Italy.

Department of Precision Medicine, University of Campania Luigi Vanvitelli, 80131 Naples, Italy.

出版信息

Int J Mol Sci. 2025 Jul 16;26(14):6825. doi: 10.3390/ijms26146825.

DOI:10.3390/ijms26146825
PMID:40725070
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12295926/
Abstract

BACKGROUND

Increased IL-1β levels may promote carcinogenesis and metastasis by affecting tumor biology and the tumor microenvironment (TME). In this context, extracellular vesicles (EVs) play a key role in cell-to-cell communication, thus modulating the TME and immune response. Here, we aimed to test whether tumor-derived small EVs (TEVs) isolated from sensitive and osimertinib-resistant (OR) non-small-cell lung cancer (NSCLC) cells may promote EMT via fibronectin binding to α5β1 integrin as well as suppress the immune system and if these effects may be favored by IL-1β.

METHODS

TEVs were isolated from control, OR, and IL-1β-stimulated NSCLC cells. Expressions of fibronectin and PD-L1 were screened in TEVs and the mRNA levels of vimentin and SMAD3 were also assessed in cancer cells after TEV co-culturing. Furthermore, to detect the effect on immune cells, we co-cultured TEVs with lung cancer patients' peripheral blood mononuclear cells (PBMCs).

RESULTS

TEVs were positive for fibronectin and the highest protein levels were found in TEVs obtained from the OR and IL-1β-stimulated cells. TEV-mediated activation of α5β1 signaling led to the upregulation of vimentin and SMAD3 mRNA in NSCLC cells and stimulated cell migration. EVs also increased PD-1, CTLA-4, FOXP3, TNF-α, IL-12, and INF-γ mRNA in lung cancer patients' immune cells.

CONCLUSIONS

Our findings indicate that TEVs promote EMT in NSCLC cells by the activation of the fibronectin-α5β1 axis. Finally, IL-1β stimulation induces TEV release with biological properties similar to OR TEVs, thus leading to cancer invasion and immune suppression and suggesting that inflammation can promote tumor spreading.

摘要

背景

白细胞介素-1β(IL-1β)水平升高可能通过影响肿瘤生物学特性和肿瘤微环境(TME)促进肿瘤发生和转移。在此背景下,细胞外囊泡(EVs)在细胞间通讯中起关键作用,从而调节TME和免疫反应。在这里,我们旨在测试从敏感和奥希替尼耐药(OR)的非小细胞肺癌(NSCLC)细胞中分离出的肿瘤源性小细胞外囊泡(TEVs)是否可通过纤连蛋白与α5β1整合素结合促进上皮-间质转化(EMT),以及是否会抑制免疫系统,以及IL-1β是否会促进这些作用。

方法

从对照、OR和IL-1β刺激的NSCLC细胞中分离TEVs。在TEVs中筛选纤连蛋白和程序性死亡配体1(PD-L1)的表达,并在TEV共培养后评估癌细胞中波形蛋白和SMAD3的mRNA水平。此外,为了检测对免疫细胞的影响,我们将TEVs与肺癌患者的外周血单个核细胞(PBMCs)共培养。

结果

TEVs纤连蛋白呈阳性,在从OR和IL-1β刺激的细胞中获得的TEVs中发现最高蛋白水平。TEV介导的α5β1信号激活导致NSCLC细胞中波形蛋白和SMAD3 mRNA上调并刺激细胞迁移。EVs还增加了肺癌患者免疫细胞中程序性死亡蛋白1(PD-1)、细胞毒性T淋巴细胞相关蛋白4(CTLA-4)、叉头框蛋白P3(FOXP3)、肿瘤坏死因子-α(TNF-α)、白细胞介素-12(IL-12)和干扰素-γ(INF-γ)的mRNA水平。

结论

我们的研究结果表明,TEVs通过激活纤连蛋白-α5β1轴促进NSCLC细胞的EMT。最后,IL-1β刺激诱导具有与OR TEVs相似生物学特性的TEV释放,从而导致癌症侵袭和免疫抑制,并表明炎症可促进肿瘤扩散。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9c3/12295926/3178a9ed6cac/ijms-26-06825-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9c3/12295926/8e9a8e64a9e6/ijms-26-06825-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9c3/12295926/6128a1d97e14/ijms-26-06825-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9c3/12295926/4dd4ddd2fa7e/ijms-26-06825-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9c3/12295926/93a6543b7181/ijms-26-06825-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9c3/12295926/80a99c8b9403/ijms-26-06825-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9c3/12295926/fb53a2c86301/ijms-26-06825-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9c3/12295926/3178a9ed6cac/ijms-26-06825-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9c3/12295926/8e9a8e64a9e6/ijms-26-06825-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9c3/12295926/6128a1d97e14/ijms-26-06825-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9c3/12295926/4dd4ddd2fa7e/ijms-26-06825-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9c3/12295926/93a6543b7181/ijms-26-06825-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9c3/12295926/80a99c8b9403/ijms-26-06825-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9c3/12295926/fb53a2c86301/ijms-26-06825-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9c3/12295926/3178a9ed6cac/ijms-26-06825-g007.jpg

相似文献

1
Effect of IL-1β on NSCLC-Derived Small Extracellular Vesicles as Actors in Mediating Cancer Progression and Evading Immune System.白细胞介素-1β对非小细胞肺癌衍生的小细胞外囊泡在介导癌症进展和逃避免疫系统中的作用
Int J Mol Sci. 2025 Jul 16;26(14):6825. doi: 10.3390/ijms26146825.
2
Comprehensive Review: Unveiling the Pro-Oncogenic Roles of IL-1ß and PD-1/PD-L1 in NSCLC Development and Targeting Their Pathways for Clinical Management.全面综述:揭示 IL-1ß 和 PD-1/PD-L1 在 NSCLC 发展中的致癌作用,并针对其通路进行临床管理。
Int J Mol Sci. 2023 Jul 17;24(14):11547. doi: 10.3390/ijms241411547.
3
Integrin αVβ1-activated PYK2 promotes the progression of non-small-cell lung cancer via the STAT3-VGF axis.整合素 αVβ1 激活的 PYK2 通过 STAT3-VGF 轴促进非小细胞肺癌的进展。
Cell Commun Signal. 2024 Jun 6;22(1):313. doi: 10.1186/s12964-024-01639-1.
4
Cancer cell-derived extracellular vesicles: a potential target for overcoming tumor immunotherapy resistance and immune evasion strategies.癌细胞衍生的细胞外囊泡:克服肿瘤免疫治疗耐药性和免疫逃逸策略的潜在靶点。
Front Immunol. 2025 Jun 12;16:1601266. doi: 10.3389/fimmu.2025.1601266. eCollection 2025.
5
Human Infrapatellar Fat Pad Mesenchymal Stem Cell-derived Extracellular Vesicles Purified by Anion Exchange Chromatography Suppress Osteoarthritis Progression in a Mouse Model.阴离子交换层析法纯化的人髌下脂肪垫间充质干细胞来源细胞外囊泡抑制骨关节炎在小鼠模型中的进展。
Clin Orthop Relat Res. 2024 Jul 1;482(7):1246-1262. doi: 10.1097/CORR.0000000000003067. Epub 2024 Apr 19.
6
Serum taurine affects lung cancer progression by regulating tumor immune escape mediated by the immune microenvironment.血清牛磺酸通过调节免疫微环境介导的肿瘤免疫逃逸影响肺癌进展。
J Adv Res. 2025 Jul;73:427-442. doi: 10.1016/j.jare.2024.09.005. Epub 2024 Sep 5.
7
Serum extracellular vesicle microRNAs as potential biomarkers to predict pembrolizumab response and prognosis in metastatic non-small cell lung cancer patients.血清细胞外囊泡微小RNA作为预测转移性非小细胞肺癌患者帕博利珠单抗反应和预后的潜在生物标志物。
Front Immunol. 2025 Jun 4;16:1540906. doi: 10.3389/fimmu.2025.1540906. eCollection 2025.
8
Persistent Stimulation of Human Mesenchymal Stem/Stromal Cells with TNF-α and IFN-γ Affects the Release of Large Extracellular Vesicles with Immunoregulatory Phenotype.用肿瘤坏死因子-α(TNF-α)和干扰素-γ(IFN-γ)持续刺激人间充质干/基质细胞会影响具有免疫调节表型的大型细胞外囊泡的释放。
Stem Cells Dev. 2025 Jul;34(13-14):291-303. doi: 10.1089/scd.2025.0064. Epub 2025 May 28.
9
Nutrient deprivation and hypoxia alter T cell immune checkpoint expression: potential impact for immunotherapy.营养剥夺和缺氧改变 T 细胞免疫检查点表达:免疫治疗的潜在影响。
J Cancer Res Clin Oncol. 2023 Jul;149(8):5377-5395. doi: 10.1007/s00432-022-04440-0. Epub 2022 Nov 29.
10
Beta cell extracellular vesicle PD-L1 as a novel regulator of CD8 T cell activity and biomarker during the evolution of type 1 diabetes.β细胞细胞外囊泡PD-L1作为1型糖尿病进展过程中CD8 T细胞活性的新型调节因子和生物标志物。
Diabetologia. 2025 Feb;68(2):382-396. doi: 10.1007/s00125-024-06313-2. Epub 2024 Nov 7.

本文引用的文献

1
Combined Therapeutic Strategies Based on the Inhibition of Non-Oncogene Addiction to Improve Tumor Response in EGFR- and KRAS-Mutant Non-Small-Cell Lung Cancer.基于抑制非癌基因成瘾的联合治疗策略以改善EGFR和KRAS突变型非小细胞肺癌的肿瘤反应
Cancers (Basel). 2024 Nov 25;16(23):3941. doi: 10.3390/cancers16233941.
2
Immune-Cell-Derived Exosomes as a Potential Novel Tool to Investigate Immune Responsiveness in SCLC Patients: A Proof-of-Concept Study.免疫细胞衍生的外泌体作为研究小细胞肺癌患者免疫反应性的潜在新工具:一项概念验证研究
Cancers (Basel). 2024 Sep 14;16(18):3151. doi: 10.3390/cancers16183151.
3
IL-1β-activated PI3K/AKT and MEK/ERK pathways coordinately promote induction of partial epithelial-mesenchymal transition.
IL-1β 激活的 PI3K/AKT 和 MEK/ERK 通路协同促进部分上皮-间充质转化的诱导。
Cell Commun Signal. 2024 Aug 8;22(1):392. doi: 10.1186/s12964-024-01775-8.
4
Exosome-like Systems: From Therapies to Vaccination for Cancer Treatment and Prevention-Exploring the State of the Art.类外泌体系统:从癌症治疗与预防的疗法到疫苗接种——探索最新进展
Vaccines (Basel). 2024 May 9;12(5):519. doi: 10.3390/vaccines12050519.
5
PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer.外周血单个核细胞作为肺癌新型免疫治疗生物标志物的鉴定工具。
Biomedicines. 2024 Apr 5;12(4):809. doi: 10.3390/biomedicines12040809.
6
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches.细胞外囊泡研究的最低信息要求(MISEV2023):从基础到先进方法。
J Extracell Vesicles. 2024 Feb;13(2):e12404. doi: 10.1002/jev2.12404.
7
Extracellular vesicles as tools and targets in therapy for diseases.细胞外囊泡作为疾病治疗的工具和靶点
Signal Transduct Target Ther. 2024 Feb 5;9(1):27. doi: 10.1038/s41392-024-01735-1.
8
ITGB1 and DDR activation as novel mediators in acquired resistance to osimertinib and MEK inhibitors in EGFR-mutant NSCLC.ITGB1 和 DDR 激活作为 EGFR 突变 NSCLC 对奥希替尼和 MEK 抑制剂获得性耐药的新型介质。
Sci Rep. 2024 Jan 4;14(1):500. doi: 10.1038/s41598-023-50568-5.
9
Isolation and Characterization of Cow-, Buffalo-, Sheep- and Goat-Milk-Derived Extracellular Vesicles.牛、水牛、绵羊和山羊乳源细胞外囊泡的分离与鉴定。
Cells. 2023 Oct 20;12(20):2491. doi: 10.3390/cells12202491.
10
The lipid composition of extracellular vesicles: applications in diagnostics and therapeutic delivery.细胞外囊泡的脂质组成:在诊断和治疗递送中的应用。
Front Mol Biosci. 2023 Jul 13;10:1198044. doi: 10.3389/fmolb.2023.1198044. eCollection 2023.